Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices

Grace D Lin, R. F. Rea, S. C. Hammill, D. L. Hayes, Peter A. Brady

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Cardiac resynchronisation therapy (CRT) improves outcomes in selected patients with heart failure and left ventricular dysfunction. One mechanism of benefit is believed to be favourable ventricular remodelling. Whether CRT also decreases the frequency of ventricular arrhythmias and risk of sudden death is unknown. Objective: To determine the effect of CRT on frequency of ventricular arrhythmias and appropriate ICD therapies. Design: Retrospective cohort study. Setting: Single-centre, tertiary care facility (Mayo Clinic). Patients: 52 patients (46 male), aged 70 (SD 10) years, who underwent upgrade from an implantable cardioverter defibrillator (ICD) to a CRT-defibrillator were included. Interventions: Upgrade of ICD to CRT-defibrillator. Main Outcome Measures: Frequency of ventricular arrhythmias prior to and following upgrade to CRT device. Results: Ejection fraction increased from 22% (SD 8%) to 27% (SD 11%) following CRT. However, the frequency of non-sustained ventricular arrhythmias, sustained ventricular arrhythmias, and ventricular fibrillation was not significantly changed prior to and following CRT (2.38 (SD 9.78) vs 58.51 (SD 412.73) per patient per month, p = 0.66; 0.07 (SD 0.17) vs 0.16 (SD 0.52), p = 0.70; 0.05 (SD 0.12) vs 0.25 (SD 1.40), p = 0.12). Conclusions: CRT is not associated with a decrease in the frequency of ventricular arrhythmia or appropriate device therapy. Thus, use of CRT alone is not beneficial in decreasing the frequency of ventricular arrhythmias or the risk of appropriate ICD therapies.

Original languageEnglish (US)
Pages (from-to)186-190
Number of pages5
JournalHeart
Volume94
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Cardiac Resynchronization Therapy Devices
Cardiac Resynchronization Therapy
Implantable Defibrillators
Cardiac Arrhythmias
Defibrillators
Ventricular Remodeling
Left Ventricular Dysfunction
Ventricular Fibrillation
Sudden Death
Tertiary Care Centers
Cohort Studies
Therapeutics
Heart Failure
Retrospective Studies
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. / Lin, Grace D; Rea, R. F.; Hammill, S. C.; Hayes, D. L.; Brady, Peter A.

In: Heart, Vol. 94, No. 2, 02.2008, p. 186-190.

Research output: Contribution to journalArticle

@article{49b57dc4378144f5aac7b54f6183c00d,
title = "Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices",
abstract = "Background: Cardiac resynchronisation therapy (CRT) improves outcomes in selected patients with heart failure and left ventricular dysfunction. One mechanism of benefit is believed to be favourable ventricular remodelling. Whether CRT also decreases the frequency of ventricular arrhythmias and risk of sudden death is unknown. Objective: To determine the effect of CRT on frequency of ventricular arrhythmias and appropriate ICD therapies. Design: Retrospective cohort study. Setting: Single-centre, tertiary care facility (Mayo Clinic). Patients: 52 patients (46 male), aged 70 (SD 10) years, who underwent upgrade from an implantable cardioverter defibrillator (ICD) to a CRT-defibrillator were included. Interventions: Upgrade of ICD to CRT-defibrillator. Main Outcome Measures: Frequency of ventricular arrhythmias prior to and following upgrade to CRT device. Results: Ejection fraction increased from 22{\%} (SD 8{\%}) to 27{\%} (SD 11{\%}) following CRT. However, the frequency of non-sustained ventricular arrhythmias, sustained ventricular arrhythmias, and ventricular fibrillation was not significantly changed prior to and following CRT (2.38 (SD 9.78) vs 58.51 (SD 412.73) per patient per month, p = 0.66; 0.07 (SD 0.17) vs 0.16 (SD 0.52), p = 0.70; 0.05 (SD 0.12) vs 0.25 (SD 1.40), p = 0.12). Conclusions: CRT is not associated with a decrease in the frequency of ventricular arrhythmia or appropriate device therapy. Thus, use of CRT alone is not beneficial in decreasing the frequency of ventricular arrhythmias or the risk of appropriate ICD therapies.",
author = "Lin, {Grace D} and Rea, {R. F.} and Hammill, {S. C.} and Hayes, {D. L.} and Brady, {Peter A.}",
year = "2008",
month = "2",
doi = "10.1136/hrt.2007.118372",
language = "English (US)",
volume = "94",
pages = "186--190",
journal = "Heart",
issn = "1355-6037",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices

AU - Lin, Grace D

AU - Rea, R. F.

AU - Hammill, S. C.

AU - Hayes, D. L.

AU - Brady, Peter A.

PY - 2008/2

Y1 - 2008/2

N2 - Background: Cardiac resynchronisation therapy (CRT) improves outcomes in selected patients with heart failure and left ventricular dysfunction. One mechanism of benefit is believed to be favourable ventricular remodelling. Whether CRT also decreases the frequency of ventricular arrhythmias and risk of sudden death is unknown. Objective: To determine the effect of CRT on frequency of ventricular arrhythmias and appropriate ICD therapies. Design: Retrospective cohort study. Setting: Single-centre, tertiary care facility (Mayo Clinic). Patients: 52 patients (46 male), aged 70 (SD 10) years, who underwent upgrade from an implantable cardioverter defibrillator (ICD) to a CRT-defibrillator were included. Interventions: Upgrade of ICD to CRT-defibrillator. Main Outcome Measures: Frequency of ventricular arrhythmias prior to and following upgrade to CRT device. Results: Ejection fraction increased from 22% (SD 8%) to 27% (SD 11%) following CRT. However, the frequency of non-sustained ventricular arrhythmias, sustained ventricular arrhythmias, and ventricular fibrillation was not significantly changed prior to and following CRT (2.38 (SD 9.78) vs 58.51 (SD 412.73) per patient per month, p = 0.66; 0.07 (SD 0.17) vs 0.16 (SD 0.52), p = 0.70; 0.05 (SD 0.12) vs 0.25 (SD 1.40), p = 0.12). Conclusions: CRT is not associated with a decrease in the frequency of ventricular arrhythmia or appropriate device therapy. Thus, use of CRT alone is not beneficial in decreasing the frequency of ventricular arrhythmias or the risk of appropriate ICD therapies.

AB - Background: Cardiac resynchronisation therapy (CRT) improves outcomes in selected patients with heart failure and left ventricular dysfunction. One mechanism of benefit is believed to be favourable ventricular remodelling. Whether CRT also decreases the frequency of ventricular arrhythmias and risk of sudden death is unknown. Objective: To determine the effect of CRT on frequency of ventricular arrhythmias and appropriate ICD therapies. Design: Retrospective cohort study. Setting: Single-centre, tertiary care facility (Mayo Clinic). Patients: 52 patients (46 male), aged 70 (SD 10) years, who underwent upgrade from an implantable cardioverter defibrillator (ICD) to a CRT-defibrillator were included. Interventions: Upgrade of ICD to CRT-defibrillator. Main Outcome Measures: Frequency of ventricular arrhythmias prior to and following upgrade to CRT device. Results: Ejection fraction increased from 22% (SD 8%) to 27% (SD 11%) following CRT. However, the frequency of non-sustained ventricular arrhythmias, sustained ventricular arrhythmias, and ventricular fibrillation was not significantly changed prior to and following CRT (2.38 (SD 9.78) vs 58.51 (SD 412.73) per patient per month, p = 0.66; 0.07 (SD 0.17) vs 0.16 (SD 0.52), p = 0.70; 0.05 (SD 0.12) vs 0.25 (SD 1.40), p = 0.12). Conclusions: CRT is not associated with a decrease in the frequency of ventricular arrhythmia or appropriate device therapy. Thus, use of CRT alone is not beneficial in decreasing the frequency of ventricular arrhythmias or the risk of appropriate ICD therapies.

UR - http://www.scopus.com/inward/record.url?scp=38749134157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38749134157&partnerID=8YFLogxK

U2 - 10.1136/hrt.2007.118372

DO - 10.1136/hrt.2007.118372

M3 - Article

C2 - 17761506

AN - SCOPUS:38749134157

VL - 94

SP - 186

EP - 190

JO - Heart

JF - Heart

SN - 1355-6037

IS - 2

ER -